Breaking News Instant updates and real-time market news.

PRNB

Principia Biopharma

$29.85

0.67 (2.30%)

16:03
10/15/19
10/15
16:03
10/15/19
16:03

Principia Biopharma files to sell $125M in common stock

BofA Merrill Lynch, SVB Leerink, and Wells Fargo Securities are acting as joint book-running managers for the offering.

PRNB Principia Biopharma
$29.85

0.67 (2.30%)

07/01/19
HCWC
07/01/19
INITIATION
Target $55
HCWC
Buy
Principia Biopharma initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis started Principia Biopharma with a Buy rating and $55 price target. The company's PRN1008 could deliver a new therapy in pemphigus vulgaris and also offers a "meaningful" commercial opportunity in immune thrombocytopenia, Pantginis tells investors in a research note.
10/02/19
STFL
10/02/19
NO CHANGE
Target $45
STFL
Buy
Stifel remains buyer of Principia Biopharma into Q4 data readouts
Stifel analyst Derek Archila remains bullish and a buyer of Principia Biopharma (PRNB) shares ahead of the company's two Phase 2 readouts for PRN1008 in immune thrombocytopenia and pemphigus vulgaris. The shares could reach the mid-$50 range if results are positive, Archila tells investors in a research note. He believes the bogey for each study is not that high and keeps a Buy rating on Principia with a $45 price target. The two clinical catalysts, coupled with Phase 2 data expected in the first half of 2020 from the company's partnered program with Sanofi (SNY) in multiple sclerosis, offers "multiple shots for valuation creation" over the next nine months.
10/10/19
STFL
10/10/19
NO CHANGE
Target $51
STFL
Buy
Principia Biopharma price target raised to $51 from $45 at Stifel
Stifel analyst Derek Archila raised his price target on Principia Biopharma shares to $51 from $45 after the company reported PRN1008 has demonstrated a complete response rate ahead of his expectations thus far in the company's its Phase 2 extension study in pemphigus vulgaris. More importantly, PRN1008 replicated its benign safety and tolerability profile at 24 weeks, even at higher dosing, Archila tells investors. The analyst, who said he would be "buying the stock here," maintains a Buy rating and keeps it on Stifel's Select List.
10/10/19
HCWC
10/10/19
NO CHANGE
HCWC
Principia announces 'positive' data from Phase 2 trial, says H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $55 price target on Principia Biopharma after the company announced positive interim data from the open label Part B of its PRN1008 Phase 2 trial in pemphigus vulgaris, or PV, which included the selection of an optimized dosing. In a note to investors titled 'Consistency Is the Message of the Day for PV Efficacy,' the analyst said the Phase 2 results helped to boost his confidence in the ongoing Pegasus Phase 3 trial of PRN1008 in PV.

TODAY'S FREE FLY STORIES

XONE

ExOne

$7.00

-0.05 (-0.71%)

, ANSS

Ansys

$238.67

3.63 (1.54%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Hot Stocks
ExOne announces collaboration with Ansys »

ExOne (XONE) and ANSYS…

XONE

ExOne

$7.00

-0.05 (-0.71%)

ANSS

Ansys

$238.67

3.63 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

, BBIO

BridgeBio

$29.06

0.8 (2.83%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Recommendations
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray »

Piper Jaffray analyst…

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

BBIO

BridgeBio

$29.06

0.8 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

05:01
11/19/19
11/19
05:01
11/19/19
05:01
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.54

0.18 (0.34%)

04:59
11/19/19
11/19
04:59
11/19/19
04:59
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CSL

Carlisle

$161.08

0.12 (0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Carlisle management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KRP

Kimbell Royalty Partners

$14.18

0.19 (1.36%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Kimbell Royalty Partners management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SU

Suncor

$31.84

-0.64 (-1.97%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Suncor management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ASML

ASML

$273.38

-1.35 (-0.49%)

, ERIC

Ericsson

$9.10

-0.04 (-0.44%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
JPMorgan to hold a conference »

Global TMT…

ASML

ASML

$273.38

-1.35 (-0.49%)

ERIC

Ericsson

$9.10

-0.04 (-0.44%)

IMAX

Imax

$20.88

-0.19 (-0.90%)

SIMO

Silicon Motion

$42.65

0.03 (0.07%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 06

    Jan

ACCO

Acco Brands

$9.42

0.035 (0.37%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Acco Brands management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stephens business services analyst to hold a group luncheon »

Group Luncheon Meeting to…

CSGS

CSG

$57.54

0.54 (0.95%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
CSG management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

ADM

Archer Daniels

$42.84

-0.03 (-0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Archer Daniels management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AHT

Ashford Hospitality

$2.70

-0.005 (-0.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ashford Hospitality management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMSF

Amerisafe

$65.49

-0.15 (-0.23%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Amerisafe management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

ESVIF

Ensign Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Ensign Energy management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FC

Franklin Covey

$37.20

-0.3 (-0.80%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Franklin Covey management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PSNL

Personalis

$8.89

-0.85 (-8.73%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Personalis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

SLNG

Stabilis Energy

$0.00

(0.00%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stabilis Energy management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

DZSI

Dasan Zhone

$7.58

-0.17 (-2.19%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Dasan Zhone management to meet with B. Riley FBR »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Securities Industry & Financial Markets Association to hold annual meeting »

SIFMA Annual Meeting 2019…

EBSB

Meridian Bancorp

$20.04

0.07 (0.35%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Meridian Bancorp management to meet with Compass Point »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Deutsche Bank to hold a conference »

Japan Consumer &…

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Raymond James to hold a conference »

Growth & Value…

CNR

Cornerstone Building Brands

$6.91

-0.015 (-0.22%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Recommendations
Cornerstone Building Brands analyst commentary  »

Cornerstone Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.